Level Biotechnology Inc. (3118.TWO)
TWD 32.0
(0.0%)
TWD 32.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 13.5 Million TWD | 6.05% |
| 2022 | 12.73 Million TWD | -4.71% |
| 2021 | 13.36 Million TWD | -15.84% |
| 2020 | 15.87 Million TWD | 616.06% |
| 2019 | 2.21 Million TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 14.83 Million TWD | 9.85% |
| 2024 Q2 | 15.08 Million TWD | 1.69% |
| 2023 Q4 | 13.5 Million TWD | -6.04% |
| 2023 FY | 13.5 Million TWD | 6.05% |
| 2023 Q1 | 11.9 Million TWD | 305.93% |
| 2023 Q2 | 11.19 Million TWD | -5.93% |
| 2023 Q3 | 14.37 Million TWD | 28.35% |
| 2022 Q4 | 2.93 Million TWD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 113.44 Million TWD | 88.098% |
| Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 95.239% |
| Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -1451.954% |
| Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 94.974% |
| NaviFUS Corp. | 32.69 Million TWD | 58.701% |
| G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -148.61% |
| TaiRx, Inc. | 12.28 Million TWD | -9.897% |
| Sinew Pharma Inc. | 6.46 Million TWD | -108.88% |
| Lin BioScience, Inc. | 42.87 Million TWD | 68.507% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -1053.032% |
| Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | -7.074% |
| Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -876.283% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 96.648% |
| AP Biosciences Inc | 82.07 Million TWD | 83.55% |
| Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 92.244% |
| RBC Bioscience Corporation | 487.36 Million TWD | 97.23% |
| Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 98.02% |
| EirGenix Inc. | 465.16 Million TWD | 97.097% |
| Enimmune corporation | 45.73 Million TWD | 70.477% |
| Lukas Biomedical Inc. | 82.55 Million TWD | 83.645% |
| BRIM Biotechnology, Inc. | 3.59 Million TWD | -275.891% |
| 3D Global Biotech Inc. | 10.37 Million TWD | -30.09% |
| TaiMed Biologics Inc. | 750.85 Million TWD | 98.202% |
| Mycenax Biotech Inc. | 726.27 Million TWD | 98.141% |
| TCI GENE Inc. | 6.79 Million TWD | -98.705% |
| SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -538.694% |
| Oneness Biotech Co., Ltd. | 397.95 Million TWD | 96.607% |
| Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -210.106% |
| Feng Chi Biotech Corp. | 10.79 Million TWD | -25.042% |
| NeoCore Technology Co., Ltd. | 96.89 Million TWD | 86.065% |
| TWi Biotechnology, Inc. | 7.97 Million TWD | -69.389% |
| Neith Corporation | 3.54 Million TWD | -281.305% |
| Sunny Pharmtech Inc. | 391.42 Million TWD | 96.551% |
| VBI | - TWD | -Infinity% |
| Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -128.925% |
| GeneReach Biotechnology Corp. | 257.03 Million TWD | 94.747% |
| Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -2409.665% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | 50.216% |
| MegaPro Biomedical Co., Ltd | 8.31 Million TWD | -62.323% |
| Visgeneer Inc. | 158.6 Million TWD | 91.487% |
| Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 93.116% |
| BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 76.803% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 96.762% |
| Sagittarius Life Science Corp | 13.32 Million TWD | -1.344% |
| BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | -3.132% |
| GlycoNex Incorporation | 900 Thousand TWD | -1400.222% |
| Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.536% |
| Pharmosa Biopharm Inc. | 144.36 Million TWD | 90.648% |
| PharmaEngine, Inc. | 14.8 Million TWD | 8.826% |
| Intech Biopharm Corporation | 1.43 Billion TWD | 99.059% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 95.782% |
| BiOptic Inc. | 93.19 Million TWD | 85.513% |
| TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 81.922% |
| Senhwa Biosciences, Inc. | 9.6 Million TWD | -40.631% |
| NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | -26.4% |
| OBI Pharma, Inc. | 501.05 Million TWD | 97.305% |
| Savior Lifetec Corporation | 270.37 Million TWD | 95.006% |
| Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | 6.073% |
| Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 99.316% |
| Meribank Biotech Co., Ltd | 34.03 Million TWD | 60.334% |
| Acepodia, Inc. | 273.81 Million TWD | 95.069% |
| Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | 34.001% |